39 results on '"Currier, Judith S"'
Search Results
2. Long-Term Follow-Up of HIV-Infected Individuals Who Have Significant Increases in CD4⁺ Cell Counts during Antiretroviral Therapy
3. Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
4. Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection
5. A Prospective, Randomized Trial Examining the Efficacy and Safety of Clarithromycin in Combination with Ethambutol, Rifabutin, or Both for the Treatment of Disseminated Mycobacterium avium Complex Disease in Persons with Acquired Immunodeficiency Syndrome
6. Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
7. Association of Adherence to Mycobacterium avium Complex Prophylaxis and Antiretroviral Therapy with Clinical Outcomes in Acquired Immunodeficiency Syndrome
8. A Randomized Study of the Utility of Human Immunodeficiency Virus RNA Measurement for the Management of Antiretroviral Therapy
9. Impact of Prophylaxis for Mycobacterium avium Complex on Bacterial Infections in Patients with Advanced Human Immunodeficiency Virus Disease
10. Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group
11. Discontinuing Prophylaxis for Opportunistic Infection: Guiding Principles
12. Health Values of Patients Infected with Human Immunodeficiency Virus: Relationship to Mental Health and Physical Functioning
13. Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
14. HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative
15. Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIVinfected Male Partners
16. Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir
17. Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation
18. Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
19. Concurrent Anemia and Elevated C-Reative Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation
20. Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257
21. How Infrequent Are Opportunistic Diseases and Immune Reconstitution Syndromes among HIV-Infected Individuals Who Have Favorable CD4⁺ Cell Count Responses to Antiretroviral Therapy? [with Reply]
22. Antiretroviral Therapy and Efficacy After Virologic Failure on First-line Boosted Protease Inhibitor Regimens
23. Biomarkers of Microbial Translocation and Macrophage Activation: Association With Progression of Subclinical Atherosclerosis in HIV-1 Infection
24. A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4 + T-Cell Recovery Despite Sustained Virologic Suppression: ACTG A5256
25. Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine
26. Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
27. Availability of HIV Postexposure Prophylaxis Services in Los Angeles County
28. Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group A5211
29. Incomplete Immune Reconstitution after Initiation of Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients with Severe CD4⁺ Cell Depletion
30. A Study of Discontinuing Maintenance Therapy in Human Immunodeficiency Virus-Infected Subjects with Disseminated Mycobacterium avium Complex: AIDS Clinical Trial Group 393 Study Team
31. Indinavir, Nevirapine, Stavudine, and Lamivudine for Human Immunodeficiency Virus-Infected, Amprenavir-Experienced Subjects: AIDS Clinical Trials Group Protocol 373
32. The Effects of Protease Inhibitor Therapy on Human Immunodeficiency Virus Type 1 Levels in Semen (AIDS Clinical Trials Group Protocol 850)
33. Treatment with Amprenavir Alone or Amprenavir with Zidovudine and Lamivudine in Adults with Human Immunodeficiency Virus Infection
34. Infectious Disease Rounds: Problems in the Management of Falciparum Malaria
35. Perioperative Antimicrobial Prophylaxis in Middle Tennessee, 1989-1990
36. Editorial Commentary: Sex Differences in Antiretroviral Therapy Toxicity: Lactic Acidosis, Stavudine, and Women
37. Localized Osteomyelitis Due to Mycobacterium avium Complex in Patients with Human Immunodeficiency Virus Receiving Highly Active Antiretroviral Therapy [Abstract]
38. Electronic Surveillance of Antibiotic Exposure and Coded Discharge Diagnoses as Indicators of Postoperative Infection and Other Quality Assurance Measures
39. Textbook of AIDS Medicine Samuel Broder Thomas C. Merigan, Jr. Dani Bolognesi
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.